Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #228093 on Biotech Values
biocqr
01/09/20 4:36 PM
#228097 RE: DewDiligence #228093
DewDiligence
05/11/20 12:17 PM
#232221 RE: DewDiligence #228093
“Our renaming both distinguishes Protara and reinforces our commitment to the patients we hope to serve by developing potentially transformative therapies,” said Jesse Shefferman, Chief Executive Officer of Protara.